Argipressin(4¡ª8)
Upregulate CTP: Phosphocholine Cytidylyltransferase in Rat Hippocampal Neurons
XU Kan-Yan, XIONG Ying, DU Yu-Cang*
( Institute of Biochemistry and Cell Biology, Shanghai Institutes for
Biological Sciences, the Chinese Academy of Sciences, Shanghai 200031, China
)
Abstract In order to
study the effect of argipressin(4¡ª8)(AVP4¡ª8) on the mRNA level and
activity of cytidine triphosphate: phosphocholine cytidylyltransferase(CCT) in
rat hippocampal neurons, and elucidate it's possible mechanism. Rat hippocampal
neurons treated with AVP4¡ª8 or actinomycin D were incubated with
different time periods. The mRNA level of CCT was detected using RT-PCR plus
Southern blot, CCT activity was determined by measuring the rate of
incorporation of £Û14C£Ý- phosphocholine into cytidine
diphosphate-choline(CDP-choline). It was found that AVP4¡ª8 could
upregulate the CCT mRNA in rat hippocampal neurons. ZDC(C)PR, the antagonist of
AVP4¡ª8, could greatly inhibit this upregulation. Using actinomycin D
to inhibite the eucaryotic transcription, it was found that the halflife of CCT
mRNA could be prolonged by coincubation with AVP4¡ª8. Meanwhile, AVP4¡ª8
could also increase CCT activity in rat hippocampal neurons. These results
demonstrated that AVP4¡ª8 upregulated CCT mRNA level and its activity
through stabilizing the CCT mRNA in rat hippocampal neurons.
Key words argipressin; CTP: phosphocholine
cytidylyltransferase; hippocampus; phosphatidylcholine; actinomycin D
*Corresponding author: Tel,
86-21-64374430; Fax, 86-21-64338357£» e-mail, duyc@ sunm.shnc.ac.cn